The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIconic Labs Regulatory News (ICON)

  • This share is currently suspended. It was suspended at a price of 5.375

Share Price Information for Iconic Labs (ICON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.375
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5.375
ICON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of AGM

4 Aug 2023 16:19

RNS Number : 4036I
Iconic Labs PLC
04 August 2023
 

V2 YJ [04.08.23]

04 August 2023

 

Iconic Labs PLC

 

("Iconic" or the "Company")

 

Notice of AGM and Proposed Share Consolidation

 

Iconic Labs PLC (LSE: ICON) announces that its Annual General Meeting ('AGM') will be held on Friday, 25 August 2023 at 3.00 p.m. at the offices of RWK Goodman, 69 Carter Lane, London, EC4V 5EQ.

 

The Notice of AGM has been posted to Shareholders and will be available to view shortly on the Company's website at: https://www.iconiclabs.co.uk/documents/.

 Introduction

 

The Board proposes to consolidate the Company's share capital with the aim of improving the marketability of the ordinary shares.

 

The purpose of this document is to provide you with details of the Share Consolidation to be proposed to Shareholders at the forthcoming Annual General Meeting.

 

Background to and reasons for the Share Consolidation

As at the date of this document, the Company has 46,306,916,660 Existing Ordinary Shares in issue. The primary objective of the consolidation is to reduce the number of ordinary shares, with the intention of creating a higher share price per ordinary share in the capital of the Company, which the Board believes will make the Company and the ordinary shares more attractive to a broader range of investors.

It is therefore proposed that the 46,306,916,660 Existing Ordinary Shares of £0.00001 each are consolidated on a 10,000 for 1 basis, such that every 10,000 Existing Ordinary Shares are consolidated into 1 ordinary share of £0.1 in nominal value. It is intended that additional New Ordinary Shares will be allotted, following the AGM so that the total number of Existing Ordinary Shares is exactly divisible by 10,000 for the share consolidation. Assuming a share capital of 46,306,916,660 Existing Ordinary Shares immediately prior to the Record Date, following completion of the Share Consolidation, the Company will have 4,630,692 New Ordinary Shares in issue.

Application will be made in accordance with the Main Market Rules for the New Ordinary Shares arising from the Share Consolidation to be admitted to trading on the Main Market, subject to Shareholders passing Resolution 9 at the Annual General Meeting. It is expected that if such Resolution is passed, Admission in respect of such New Ordinary Shares will become effective and that dealings in those New Ordinary Shares will commence on 28 August 2023.

No Shareholder will be entitled to a fraction of a New Ordinary Share. Instead, their entitlement will be rounded down to the nearest whole number of New Ordinary Shares. Remaining fractional entitlements to New Ordinary Shares will be aggregated and sold on behalf, and for the benefit of, the Company. If a Shareholder holds fewer than 10,000 Existing Ordinary Shares at the Record Date, then the rounding down process will result in that Shareholder being entitled to zero New Ordinary Shares and as a result of the Share Consolidation they will cease to hold any Ordinary Shares.

 

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

2023

Posting of the AGM Notice

2 August

Latest time and date for receipt of forms of proxy for the Annual General Meeting

 

3.00 p.m. on 23 August

 

Annual General Meeting

3.00 p.m. on 25 August

Announcement of the result of the Annual General Meeting

25 August

Record Date in respect of the Share Consolidation and final date for trading in Existing Ordinary Shares

6.00 p.m. on 25 August

Admission expected to become effective and dealings expected to commence in the New Ordinary Shares on the Main Market

8.00 a.m. on 29 August

CREST accounts expected to be credited in respect of New Ordinary Shares in uncertificated form

29 August

Expected date by which certificates in respect of New Ordinary Shares are to be despatched to certificated Shareholders

By the week commencing 11 September

 

 

- Ends -

 

For more information, please contact:

Iconic Labs

 

Brad Taylor, Chief Executive Officer

Tel: +44 (0) 7462 156238

Novum Securities Limited

David Coffman / Daniel Harris

Tel: +44 (0) 20 7399 9400

 

Yellow Jersey PR

Sarah Hollins

Annabelle Wills

Bessie Elliot

 

Tel: +44 (0) 20 3004 9512

iconic@yellowjerseypr.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAUPURARUPWGWC
Date   Source Headline
30th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Jan 20238:04 amRNSConversion of Securities & Resignation of Director
27th Jan 202311:05 amRNSSecond Price Monitoring Extn
27th Jan 202311:00 amRNSPrice Monitoring Extension
25th Jan 202312:08 pmRNSRestoration of Trading
25th Jan 20239:00 amRNSPrice Monitoring Extension
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
24th Jan 202312:00 pmRNSRestoration - Iconic Labs Plc
16th Jan 20235:24 pmRNSUpdate Regarding Sting Industries Acquisition
16th Jan 20237:00 amRNSIPEM
6th Jan 20238:10 amRNSCorporate Update
3rd Jan 20234:48 pmRNSAnnual Financial Report 2022
29th Dec 20223:58 pmRNSFinal Results 2021
22nd Dec 20229:02 amRNSFinancing Facility
16th Dec 20227:00 amRNSRegulatory Approval
14th Dec 20226:31 pmRNSDirectorate Change
30th Nov 202211:15 amRNSConversion of Securities
1st Nov 20224:50 pmRNSSubscription of convertible notes
22nd Sep 20225:59 pmRNSResults of Creditors and General Meetings
30th Aug 20226:19 pmRNSSettlement and CVA
23rd Aug 20224:57 pmRNSRetraction of claims
8th Jun 20226:05 pmRNSAdministration & proposed CVA update
8th Dec 20216:21 pmRNSResults of General Meeting
26th Nov 202110:05 amRNSAdjournment to the GM
19th Nov 202111:25 amRNSAdjournment to the GM - Replacement
18th Nov 20214:00 pmRNSAdjournment to the GM
15th Nov 20214:54 pmRNSAdjournment of General Meeting
7th Oct 202110:33 amRNSGeneral Meeting – Further adjournment
25th Aug 20212:44 pmRNSNOTICE OF APPROVAL OF ADMINISTRATORS' PROPOSALS
12th Aug 20211:22 pmRNSGM update and adjournment notice
13th Jul 20216:38 pmRNSGM update and adjournment notice
1st Jul 20214:48 pmRNSGM update and adjournment notice
16th Jun 20214:56 pmRNSAnnouncement of resignation of directorship
15th Jun 20214:27 pmRNSUpdate on General Meeting
7th Jun 20217:30 amRNSSuspension - Iconic Labs Plc
4th Jun 20216:39 pmRNSAppointment of Administrators
1st Jun 20219:05 amRNSSecond Price Monitoring Extn
1st Jun 20219:00 amRNSPrice Monitoring Extension
26th May 20214:55 pmRNSDirectorate Change
24th May 20212:06 pmRNSSecond Price Monitoring Extn
24th May 20212:00 pmRNSPrice Monitoring Extension
24th May 202111:05 amRNSSecond Price Monitoring Extn
24th May 202111:00 amRNSPrice Monitoring Extension
24th May 20219:36 amRNSDirectorate Change
24th May 20219:05 amRNSSecond Price Monitoring Extn
24th May 20219:00 amRNSPrice Monitoring Extension
21st May 20217:00 amRNSNotice of GM
20th May 202111:05 amRNSSecond Price Monitoring Extn
20th May 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.